King's College London

Research portal

Corrigendum to “Discovery and lead optimisation of a potent, selective and orally bioavailable RARβ agonist for the potential treatment of nerve injury” (Bioorganic & Medicinal Chemistry Letters (2019) 29(8) (995–1000), (S0960894X19300873), (10.1016/j.bmcl.2019.02.011))

Research output: Contribution to journalComment/debate

Maria B. Goncalves, Earl Clarke, Christopher I. Jarvis, S. Barret Kalindjian, Thomas Pitcher, John Grist, Carl Hobbs, Thomas Carlstedt, Julian Jack, Jane T. Brown, Mark Mills, Peter Mumford, Alan D. Borthwick, Jonathan P.T. Corcoran

Original languageEnglish
Pages (from-to)1-2
Number of pages2
JournalBIOORGANIC AND MEDICINAL CHEMISTRY LETTERS
DOIs
Publication statusPublished - 14 Jun 2019

King's Authors

Abstract

The authors regret that a mistake was made in the headings of Tables 2 and 3. The correct Tables 2 and 3 appear below. The authors would like to apologise for any inconvenience caused.

View graph of relations

© 2018 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454